{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, IDs, or identifiers along with bioactivity metrics, numeric values, and units. The text primarily discusses methods, formulations, and general concepts related to protein kinase inhibitors and their delivery, without providing specific data that includes all four required components."}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics, numeric values, and units that are required to be extracted. The text appears to be a descriptive passage about hybrid nanoparticles, protein kinase inhibitors, and polymeric stabilizing and matrix-forming components, but it does not provide specific data that meets the extraction criteria."}
{"raw_mentions": "There are no sentences that contain all four required components: a specific molecule name, ID or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value. The text appears to be a general description of a method for forming hybrid nanoparticles and does not include specific data on bioactivity metrics."}
{"raw_mentions": "There are no sentences that meet the specified criteria, as none of the sentences contain a specific molecule name, ID, or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value. The text primarily discusses methods and calculations in general terms, without providing specific data or measurements for a particular molecule or protein kinase inhibitor."}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics, numeric values, and units that are required to be extracted. The text primarily describes compositions, embodiments, and properties of nanoparticles and protein kinase inhibitors in general terms, without providing specific data that includes all four required components."}
{"raw_mentions": "There are no sentences that meet the specified criteria, as none of the sentences contain a specific molecule name, ID, or identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value. The text primarily discusses methods, calculations, and general descriptions of pharmaceutical compositions, without providing specific data that meets the required criteria."}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nAxitinib 160, 162 & 5% 25% DMSO 25\u00b0C /Kollidon 581 & C0<sub>2</sub> & 125 Bars VA64\nCrizotinib 153, 155, 5% 25% DMSO 25\u00b0C /PVP 30K 156 & 571 & co<sub>2</sub> & 125 Bars\nDasatinib 140, 141 & 4% 35% DMSO/Acetone 15\u00b0C /Kollidon 551 (1:2) & C0<sub>2</sub> & 125 Bars VA64\nErlotinib HCI 511 3.6% 35% TFE 25\u00b0C /HPMC AS & C0<sub>2</sub> & 150 Bars\nGefitinib 135, 137 & 4% 35% DMSO/Acetone 40\u00b0C /HPMCP HP55 541 (1:2) & C02 & 150 Bars\nLapatinib base 531 5% 66% DMSO/Acetone 40\u00b0C /HPC If (1:2) & C02 & 150 Bars\nNilotinib base 501 5% 40% TFE 15\u00b0C /HPMCP HP55 & co<sub>2</sub> & 125 Bars\nPazopanib HCI 521 3.6% 35% TFE 25\u00b0C /PVP 90K & co<sub>2</sub> & 150 Bars\nSorafenib 561 4% 35% DMSO/Acetone 40\u00b0C tosylate (1:2) & C02 & 150 Bars /HPMCP HP55\nVemurafenib 168, 170 & 5% 25% DMSO 25\u00b0C /CAP 592 & co<sub>2</sub> & 125 Bars\n\n\nNote that these rows are from Table A and contain information about the protein kinase inhibitors (PKIs), polymeric stabilizing and matrix-forming components, solvents, antisolvents, and conditions. However, they do not contain bioactivity metrics such as IC50, Ki, Kd, EC50, pIC50, pEC50, pKi, or pKd. \n\nIf you would like to extract sentences/rows with bioactivity metrics, please let me know and I can try to help you with that."}
{"final_json": [{"molecule_name": "Axitinib", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "Crizotinib", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "Dasatinib", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "Erlotinib HCI", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "Gefitinib", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "Lapatinib base", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "Nilotinib base", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "Pazopanib HCI", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "Sorafenib", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "Vemurafenib", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nErlotinib HCI  58 1 100 - - 28.9 6.25 4.6 \nErlotinib HCI H PMC- AS  59 l+P 100 - 23 53.2 84"}
{"final_json": [{"molecule_name": "Erlotinib HCI", "protein_target_name": null, "binding_metric": null, "value": "28.9", "unit": null, "is_logarithmic": false}, {"molecule_name": "Erlotinib HCI H PMC- AS", "protein_target_name": null, "binding_metric": null, "value": "53.2", "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nPazopanib (raw)  84  I  100  -  46.2  24.4  15.0 \nPazopanib (raw) PVP 90K  85  l+P  100  -  82.7  83.8  67.7"}
{"final_json": [{"molecule_name": "Pazopanib (raw)", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "Pazopanib (raw) PVP 90K", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nLapatinib (base) 110 1 100 - - 2.9 6.0 6.5 \nLapatinib (salt) 111 1 100 - - 57.7 132.2 124.2 \nLapatinib (salt) Soluplus 112 l+S 100 - 67.6 142.9 140.0 \nLapatinib (salt) Soluplus 113 l+S 100 - 144.7 283.6 204.0 \nLapatinib (base) HPC LF 114 l+P 100 - 1.9 4.9 6.1 \nLapatinib (salt) HPC LF 115 l+P 100 - 56.7 93.8 81.8 \nLapatinib (base) HPC LF Soluplus 116 l+P+S 100 5.5 22.5 52.0 \n\n\nNote that the units for the values are not explicitly stated in the table, but based on the context, it appears that the concentrations are in mg/L."}
{"final_json": [{"molecule_name": "Lapatinib (base)", "protein_target_name": null, "binding_metric": null, "value": "2.9", "unit": "mg/L", "is_logarithmic": false}, {"molecule_name": "Lapatinib (salt)", "protein_target_name": null, "binding_metric": null, "value": "57.7", "unit": "mg/L", "is_logarithmic": false}, {"molecule_name": "Lapatinib (salt) Soluplus", "protein_target_name": null, "binding_metric": null, "value": "67.6", "unit": "mg/L", "is_logarithmic": false}, {"molecule_name": "Lapatinib (salt) Soluplus", "protein_target_name": null, "binding_metric": null, "value": "144.7", "unit": "mg/L", "is_logarithmic": false}, {"molecule_name": "Lapatinib (base) HPC LF", "protein_target_name": null, "binding_metric": null, "value": "1.9", "unit": "mg/L", "is_logarithmic": false}, {"molecule_name": "Lapatinib (salt) HPC LF", "protein_target_name": null, "binding_metric": null, "value": "56.7", "unit": "mg/L", "is_logarithmic": false}, {"molecule_name": "Lapatinib (base) HPC LF Soluplus", "protein_target_name": null, "binding_metric": null, "value": "5.5", "unit": "mg/L", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nGefitinib (raw)  131 1 100 - - 15.3 5967 - 1000 mg \nGefitinib (raw) PVP30K Soluplus  132 l+P+S 35 15.8 6630 1.1 \nGefitinib (raw) HPMCP HP55 Soluplus  133 l+P+S 35 23.0 9826 1.6 \nGefitinib PVP30K  134 l/P 35 - 26.7 10954 1.8 \nGefitinib HPMCP HP55  135 l/P 35 - 32.1 12794 2.1 \nGefitinib PVP30K Soluplus  136 l/P+S 35 43.0 12282 2.9 \nGefitinib HPMCP HP55 Soluplus  137 l/P+S 35 57.6 22774 3.8 \nDasatinib (raw)  138 1 100 - - 34.5 59.7 63.5 \nDasatinib (raw) Kollidon VA64 Soluplus  139 l+P+S 35 24.2 64.9 82.5 \nDasatinib Kollidon VA64  140 l/P 35 - 54.7 382.0 417.6 \nDasatinib Kollidon VA64 Soluplus  141 l/P+S 35 199.9 599.8 643.8 \nSorafenib  142 1 tosylate (raw) 100 - - 34.4 12001 - 1000 mg \nSorafenib HPMCP HP55 Soluplus  143 l+P+S tosylate (raw) 35 33.9 11588 1.0 \nSorafenib HPMCP HP55  144 l/P tosylate 35 - 245.3 21838 1.8 \nSorafenib HPMCP HP55 Soluplus  145 l/P+S tosylate 35 335.1 52948 4.4 \nCrizotinib  150 1 100 - - 22.7 16773 \nCrizotinib PVP30K Soluplus  151 l+P+S 25 36.8 27185 1.6 \nCrizotinib PVP30K  152 l+P+S 25 RH40 42.8 30423 1.8 \nCrizotinib PVP30K  153 l/P 25 - 39.1 29958 1.8 \nCrizotinib Kollidon VA64  154 l/P 25 - 44.8 33611 2.0 \nCrizotinib PVP30K Soluplus  155 l/P+S 25 58.1 44862 2.7 \nCrizotinib PVP30K  156 l/P+S 25 RH40 85.5 64338 3.8 \nAxitinib  157 1 100 - - 0.1 47 \nAxitinib Kollidon VA64 Soluplus  158 l+P+S 25 0.2 126 2.7 \nAxitinib HPMC AS Soluplus  159 l+P+S 25 0.6 193 4.1 \nAxitinib Kollidon VA64  160 I/P 25 - 5.2 3255 69.0 \nAxitinib HPMC AS  161 I/P 25 - 4.2 1571 33.0 \nAxitinib Kollidon VA64 Soluplus  162 l/P+S 25 44.7 16070 341.0 \nAxitinib HPMC AS Soluplus  163 l/P+S 25 22.1 7954 169.0 \nVemurafenib  164 1 100 - - 0.1 27 \nVemurafenib Kollidon VA64 Soluplus  165 l+P+S 25 0.3 83 3.1 \nVemurafenib HPMC AS Soluplus  166 l+P+S 25 0.5 141 5.2 \nVemurafenib Kollidon VA64  167 l/P 25 - 2.1 1042 38.6 \nVemurafenib HPMC AS  168 l/P 25 - 1.6 531 19.7 \nVemurafenib Kollidon VA64 Soluplus  169 l/P+S 25 17.3 5571 206.0 \nVemurafenib HPMC AS Soluplus  170 l/P+S 25 10.9 2831 104.0"}
{"final_json": [{"molecule_name": "Gefitinib", "protein_target_name": null, "binding_metric": null, "value": "15.3", "unit": null, "is_logarithmic": false}, {"molecule_name": "Gefitinib", "protein_target_name": null, "binding_metric": null, "value": "15.8", "unit": null, "is_logarithmic": false}, {"molecule_name": "Gefitinib", "protein_target_name": null, "binding_metric": null, "value": "23.0", "unit": null, "is_logarithmic": false}, {"molecule_name": "Gefitinib", "protein_target_name": null, "binding_metric": null, "value": "26.7", "unit": null, "is_logarithmic": false}, {"molecule_name": "Gefitinib", "protein_target_name": null, "binding_metric": null, "value": "32.1", "unit": null, "is_logarithmic": false}, {"molecule_name": "Gefitinib", "protein_target_name": null, "binding_metric": null, "value": "43.0", "unit": null, "is_logarithmic": false}, {"molecule_name": "Gefitinib", "protein_target_name": null, "binding_metric": null, "value": "57.6", "unit": null, "is_logarithmic": false}, {"molecule_name": "Dasatinib", "protein_target_name": null, "binding_metric": null, "value": "34.5", "unit": null, "is_logarithmic": false}, {"molecule_name": "Dasatinib", "protein_target_name": null, "binding_metric": null, "value": "24.2", "unit": null, "is_logarithmic": false}, {"molecule_name": "Dasatinib", "protein_target_name": null, "binding_metric": null, "value": "54.7", "unit": null, "is_logarithmic": false}, {"molecule_name": "Dasatinib", "protein_target_name": null, "binding_metric": null, "value": "199.9", "unit": null, "is_logarithmic": false}, {"molecule_name": "Sorafenib", "protein_target_name": null, "binding_metric": null, "value": "34.4", "unit": null, "is_logarithmic": false}, {"molecule_name": "Sorafenib", "protein_target_name": null, "binding_metric": null, "value": "33.9", "unit": null, "is_logarithmic": false}, {"molecule_name": "Sorafenib", "protein_target_name": null, "binding_metric": null, "value": "245.3", "unit": null, "is_logarithmic": false}, {"molecule_name": "Sorafenib", "protein_target_name": null, "binding_metric": null, "value": "335.1", "unit": null, "is_logarithmic": false}, {"molecule_name": "Crizotinib", "protein_target_name": null, "binding_metric": null, "value": "22.7", "unit": null, "is_logarithmic": false}, {"molecule_name": "Crizotinib", "protein_target_name": null, "binding_metric": null, "value": "36.8", "unit": null, "is_logarithmic": false}, {"molecule_name": "Crizotinib", "protein_target_name": null, "binding_metric": null, "value": "42.8", "unit": null, "is_logarithmic": false}, {"molecule_name": "Crizotinib", "protein_target_name": null, "binding_metric": null, "value": "39.1", "unit": null, "is_logarithmic": false}, {"molecule_name": "Crizotinib", "protein_target_name": null, "binding_metric": null, "value": "44.8", "unit": null, "is_logarithmic": false}, {"molecule_name": "Crizotinib", "protein_target_name": null, "binding_metric": null, "value": "58.1", "unit": null, "is_logarithmic": false}, {"molecule_name": "Crizotinib", "protein_target_name": null, "binding_metric": null, "value": "85.5", "unit": null, "is_logarithmic": false}, {"molecule_name": "Axitinib", "protein_target_name": null, "binding_metric": null, "value": "0.1", "unit": null, "is_logarithmic": false}, {"molecule_name": "Axitinib", "protein_target_name": null, "binding_metric": null, "value": "0.2", "unit": null, "is_logarithmic": false}, {"molecule_name": "Axitinib", "protein_target_name": null, "binding_metric": null, "value": "0.6", "unit": null, "is_logarithmic": false}, {"molecule_name": "Axitinib", "protein_target_name": null, "binding_metric": null, "value": "5.2", "unit": null, "is_logarithmic": false}, {"molecule_name": "Axitinib", "protein_target_name": null, "binding_metric": null, "value": "4.2", "unit": null, "is_logarithmic": false}, {"molecule_name": "Axitinib", "protein_target_name": null, "binding_metric": null, "value": "44.7", "unit": null, "is_logarithmic": false}, {"molecule_name": "Axitinib", "protein_target_name": null, "binding_metric": null, "value": "22.1", "unit": null, "is_logarithmic": false}, {"molecule_name": "Vemurafenib", "protein_target_name": null, "binding_metric": null, "value": "0.1", "unit": null, "is_logarithmic": false}, {"molecule_name": "Vemurafenib", "protein_target_name": null, "binding_metric": null, "value": "0.3", "unit": null, "is_logarithmic": false}, {"molecule_name": "Vemurafenib", "protein_target_name": null, "binding_metric": null, "value": "0.5", "unit": null, "is_logarithmic": false}, {"molecule_name": "Vemurafenib", "protein_target_name": null, "binding_metric": null, "value": "2.1", "unit": null, "is_logarithmic": false}, {"molecule_name": "Vemurafenib", "protein_target_name": null, "binding_metric": null, "value": "1.6", "unit": null, "is_logarithmic": false}, {"molecule_name": "Vemurafenib", "protein_target_name": null, "binding_metric": null, "value": "17.3", "unit": null, "is_logarithmic": false}, {"molecule_name": "Vemurafenib", "protein_target_name": null, "binding_metric": null, "value": "10.9", "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nIn experiments with nilotinib HCI, 4 mg was weighed in the flow through cell (experiment 500) and compared with stable, amorphous hybrid nanoparticles of the invention with nilotinib base and the polymeric stabilizing and matrix-forming component HPMCP HP55 (experiment 501 ).\nInitial Dissolution Rate \nEXP 500 0.27 \nEXP 501 6.58 \nRatio 501/500 24.0 \n0 0.13 3.07 \n0.5 0.33 7.96 \n1 0.49 12.23 \n1.5 0.63 15.22 \n2 0.76 17.91 \n3 1.02 23.25 \n4 1.24 28.03 \n5 1.48 32.70 \n6 1.71 37.32 \n7 1.92 42.04 \n8 2.13 45.78 \n9 2.34 49.52 \n10 2.56 52.34 \n15 3.51 59.66 \n20 4.31 66.28 \n25 5.04 70.92 \n30 5.7 74.38 \n35 6.4 76.25 \n40 7.0 80.33"}
{"final_json": [{"molecule_name": "nilotinib HCI", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "nilotinib base", "protein_target_name": null, "binding_metric": "Initial Dissolution Rate", "value": "0.27", "unit": null, "is_logarithmic": false}, {"molecule_name": "nilotinib base with HPMCP HP55", "protein_target_name": null, "binding_metric": "Initial Dissolution Rate", "value": "6.58", "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Ratio", "value": "24.0", "unit": null, "is_logarithmic": false}]}
